当前位置: 首页 > 详情页

Systematic Pharmacological Methodology to Explore the Pharmacological Mechanism of Siwu Decoction for Osteoporosis

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Beijing Univ Chinese Med, Beijing, Peoples R China; [2]China Acad Chinese Mec Sci, Xiyuan Hosp, Beijing, Peoples R China; [3]Capital Med Univ, Beijing, Peoples R China; [4]Capital Med Univ, Beijing Anzhen Hosp, Beijing, Peoples R China; [5]Shantou Univ, Med Coll, Shantou, Guangdong, Peoples R China; [6]Guangdong Gen Hosp, Guangdong Geriatr Inst, Dept Rehabil Med, Guangzhou, Guangdong, Peoples R China; [7]Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China; [8]Hunan Univ Chinese Med, Changsha, Hunan, Peoples R China
出处:
ISSN:

关键词: Herbal Medicine Medicine Chinese Traditional Osteoporosis Pharmacology

摘要:
Background: Osteoporosis is an important health problem worldwide. Siwu decoction (SWD) and its modification have a good clinical effect on osteoporosis. However, the molecular mechanism of SWD on osteoporosis has not been thoroughly explained. Material/Methods: A systematic pharmacological methodology was utilized to predict the active compounds and potential targets of SWD, collect the genes of osteoporosis and the known targets of SWD, and analyze the osteoporosis and SWD's network. Results: Five networks were constructed and analyzed: (1) Osteoporosis genes' protein-protein interaction (PPI) network; (2) Compound-compound target network of SWD; (3) SWD-osteoporosis PPI network; (4) Compound-known target network of SWD; and (5) SWD known target-osteoporosis PPI network. Several osteoporosis and treatment-related targets (eg.,. HSP90ABI, FGFR1, HRAS, GRB2, and PGF), clusters, biological processes, and signaling pathways (e.g., PI3K-Akt signaling pathway, insulin signaling pathway, MAPK signaling pathway and FoxO signaling pathway) were found. Conclusions: The therapeutic effect of SWD on osteoporosis may be achieved by interfering with the biological processes and signaling pathways related to the development of osteoporosis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
JCR分区:
出版当年[2017]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q3 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Beijing Univ Chinese Med, Beijing, Peoples R China; [2]China Acad Chinese Mec Sci, Xiyuan Hosp, Beijing, Peoples R China;
通讯作者:
通讯机构: [2]China Acad Chinese Mec Sci, Xiyuan Hosp, Beijing, Peoples R China; [8]Hunan Univ Chinese Med, Changsha, Hunan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院